AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22871888 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest measured value of SBP
Number of subjects: 4396
Study 22871888 — intervention group
Group type: EXPERIMENTAL
Intervention: Variability in SBP for CHD
Number of subjects: 4396
Study 20417857 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyronaridine-artesunate (180 mg pyronaridine and 60 mg artesunate once a day for 3 days)
Number of subjects: 1272
Study 20417857 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (20 mg artemether and 120 mg lumefantrine twice a day for 3 days)
Number of subjects: 1272
Study 20417857 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyronaridine-artesunate
Number of subjects: 1272
Study 20417857 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine
Number of subjects: 1272
Study 18242616 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (160mg/d)
Number of subjects: 55
Study 16129744 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetabular cement pressurisation for 60 seconds before insertion of the acetabular component
Number of subjects: 40
Study 16129744 — intervention group
Group type: COMPARATOR
Intervention: Acetabular cement pressurisation with simultaneous vacuum suction of the ilium
Number of subjects: 40
Study 12609701 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback condition (personalized feedback and encouragement)
Number of subjects: 73
Study 12609701 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 73
Study 11236340 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of piperacillin sodium (2 g i.v. after umbilical cord clamping)
Number of subjects: 206
Study 11236340 — intervention group
Group type: COMPARATOR
Intervention: Triple doses of piperacillin sodium (2 g i.v. at 6 hourly intervals starting from umbilical cord clamping)
Number of subjects: 206
Study 8861689 — intervention group
Group type: EXPERIMENTAL
Intervention: One-arm cranking
Number of subjects: 19
Study 8861689 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-arm cranking
Number of subjects: 19
Study 8861689 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-leg cycling
Number of subjects: 19
Study 1739017 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol 300
Number of subjects: 600
Study 1739017 — intervention group
Group type: COMPARATOR
Intervention: diatrizoate meglumine 60
Number of subjects: 600
Study 6439064 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative biliary decompression
Number of subjects: 10
Study 6439064 — intervention group
Group type: COMPARATOR
Intervention: No preoperative biliary decompression (Group B)
Number of subjects: 10
Study 6439064 — intervention group
Group type: COMPARATOR
Intervention: No preoperative biliary decompression (Group C)
Number of subjects: 10
Study 6439064 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 10
Study 31484315 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat noodle ingestion
Number of subjects: 20
Study 31484315 — intervention group
Group type: COMPARATOR
Intervention: Rice noodle ingestion
Number of subjects: 20
Study 31484315 — intervention group
Group type: COMPARATOR
Intervention: Mung bean noodle ingestion
Number of subjects: 20
Study 29762764 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.6 g/kg
Number of subjects: 24
Study 29762764 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.45 g/kg
Number of subjects: 24
Study 29762764 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 27395380 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg/d (25 mg twice daily)
Number of subjects: 20
Study 27395380 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated with amitriptyline)
Number of subjects: 20
Study 24631324 — intervention group
Group type: EXPERIMENTAL
Intervention: 1Hz rTMS over the SMA for 10 consecutive days
Number of subjects: 17
Study 24631324 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 17
Study 22700528 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT) for 24 hours
Number of subjects: 180
Study 22700528 — intervention group
Group type: COMPARATOR
Intervention: Usual subcutaneous insulin for 24 hours
Number of subjects: 180
Study 22700528 — intervention group
Group type: COMPARATOR
Intervention: Usual subcutaneous insulin
Number of subjects: 180
Study 22700528 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT)
Number of subjects: 180
Study 22700528 — intervention group
Group type: COMPARATOR
Intervention: 3-month functional outcome
Number of subjects: 180
Study 22700528 — intervention group
Group type: COMPARATOR
Intervention: Death rate at 3 months
Number of subjects: 180
Study 22700528 — intervention group
Group type: COMPARATOR
Intervention: Serious adverse events at 3 months
Number of subjects: 180
Study 19776507 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.18% isotretinoin applied topically twice a day for one month
Number of subjects: 6
Study 19776507 — intervention group
Group type: COMPARATOR
Intervention: Untreated control patients
Number of subjects: 6
Study 17313376 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. 2.1 microg/kg
Number of subjects: 93
Study 17313376 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. 4.2 microg/kg
Number of subjects: 93
Study 17313376 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. 6.3 microg/kg
Number of subjects: 93
Study 15173298 — intervention group
Group type: EXPERIMENTAL
Intervention: anterior‐posterior‐glide Low Contact Stress mobile‐bearing prosthesis
Number of subjects: 190
Study 15173298 — intervention group
Group type: COMPARATOR
Intervention: rotating‐platform Low Contact Stress mobile‐bearing prosthesis
Number of subjects: 190
Study 11512369 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (2 mg.kg‐1)
Number of subjects: 60
Study 11512369 — intervention group
Group type: COMPARATOR
Intervention: Thiopental (5 mg.kg‐1)
Number of subjects: 60
Study 9742659 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ppm D4 (122 micrograms/liter)
Number of subjects: 12
Study 9742659 — intervention group
Group type: COMPARATOR
Intervention: Air (control)
Number of subjects: 12
Study 7851104 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported employment program (changed from day treatment)
Number of subjects: 183
Study 7851104 — intervention group
Group type: COMPARATOR
Intervention: Day treatment program (control)
Number of subjects: 183
Study 3508329 — intervention group
Group type: EXPERIMENTAL
Intervention: 375 mg naproxen twice daily
Number of subjects: 48
Study 3508329 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg naproxen twice daily
Number of subjects: 48
Study 30592439 — intervention group
Group type: EXPERIMENTAL
Intervention: Assistive Home Technology (AHT)
Number of subjects: 54
Study 30592439 — intervention group
Group type: COMPARATOR
Intervention: Control group (without AHT)
Number of subjects: 54
Study 29793566 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration followed by five percent topical sodium fluoride (NaF) application
Number of subjects: 45
Study 29793566 — intervention group
Group type: COMPARATOR
Intervention: Five percent sodium fluoride (NaF) alone
Number of subjects: 45
Study 28007034 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention (tele-care support)
Number of subjects: 0
Study 28007034 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0
Study 24630840 — intervention group
Group type: EXPERIMENTAL
Intervention: Tribulus terrestris 800 mg, divided into two doses per day for thirty days
Number of subjects: 30
Study 24630840 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered in the same way as the intervention
Number of subjects: 30
Study 23782752 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichuris suis ova 2,500 eggs every two weeks for 12 months
Number of subjects: 50
Study 23782752 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 50
Study 20409438 — intervention group
Group type: EXPERIMENTAL
Intervention: AA attendance
Number of subjects: 1706
Study 20409438 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of anger
Number of subjects: 1706
Study 20409438 — intervention group
Group type: COMPARATOR
Intervention: General population
Number of subjects: 1706
Study 18956493 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturopathy
Number of subjects: 2527
Study 18956493 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathy
Number of subjects: 2527
Study 18956493 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 2527
Study 18956493 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic
Number of subjects: 2527
Study 16182024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical spinal joint dysfunction at multiple sites
Number of subjects: 30
Study 12207107 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-resistant depression (TRD)
Number of subjects: 158
Study 12207107 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment-resistant depression (non-TRD)
Number of subjects: 158
Study 10408182 — intervention group
Group type: EXPERIMENTAL
Intervention: New sampling design based on individual information contribution
Number of subjects: 0
Study 10408182 — intervention group
Group type: COMPARATOR
Intervention: Control subjects sampled from risk sets or entire cohort
Number of subjects: 0
Study 8727629 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional-tip endotracheal tubes
Number of subjects: 49
Study 8727629 — intervention group
Group type: COMPARATOR
Intervention: Standard endotracheal tubes
Number of subjects: 49
Study 1773636 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT)
Number of subjects: 108
Study 1773636 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Assessment
Number of subjects: 108
Study 7053283 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfinpyrazone, 400 mg daily
Number of subjects: 6
Study 7053283 — intervention group
Group type: EXPERIMENTAL
Intervention: S-warfarin with sulfinpyrazone
Number of subjects: 6
Study 7053283 — intervention group
Group type: EXPERIMENTAL
Intervention: R-warfarin with sulfinpyrazone
Number of subjects: 6
Study 30074288 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 T static magnetic field exposure
Number of subjects: 18
Study 30074288 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 T static magnetic field exposure
Number of subjects: 18
Study 30074288 — intervention group
Group type: COMPARATOR
Intervention: 0 T (placebo) static magnetic field exposure
Number of subjects: 18
Study 27513640 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural 0.125% ropivacaine with dexmedetomidine (0.5 μg/kg)
Number of subjects: 80
Study 27513640 — intervention group
Group type: COMPARATOR
Intervention: Epidural 0.125% ropivacaine
Number of subjects: 80
Study 24923890 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face interview (FTFI)
Number of subjects: 368
Study 24923890 — intervention group
Group type: COMPARATOR
Intervention: Computer-assisted self-interview (CASI)
Number of subjects: 368
Study 23531984 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based photoaging intervention using APRIL Face Aging software
Number of subjects: 160
Study 23531984 — intervention group
Group type: COMPARATOR
Intervention: Standardized smoking cessation advice (Control)
Number of subjects: 160
Study 23531984 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group smoking dependence score
Number of subjects: 160
Study 21336156 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple sequential therapy plus 6 weeks of iron supplementation
Number of subjects: 110
Study 21336156 — intervention group
Group type: COMPARATOR
Intervention: Eradication therapy plus placebo
Number of subjects: 110
Study 21336156 — intervention group
Group type: COMPARATOR
Intervention: Iron supplementation plus placebo
Number of subjects: 110
Study 21336156 — intervention group
Group type: COMPARATOR
Intervention: Placebo only
Number of subjects: 110
Study 19839000 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Tea Extracts (GTE)
Number of subjects: 10
Study 19839000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 15998749 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g of isolated soybean protein supplements per day
Number of subjects: 302
Study 15998749 — intervention group
Group type: COMPARATOR
Intervention: Complex carbohydrate control
Number of subjects: 302
Study 12891107 — intervention group
Group type: EXPERIMENTAL
Intervention: SMCD (Suture-Mediated Closure Device)
Number of subjects: 102
Study 12891107 — intervention group
Group type: COMPARATOR
Intervention: Manual Compression
Number of subjects: 102
Study 12891107 — intervention group
Group type: EXPERIMENTAL
Intervention: SMCD
Number of subjects: 102
Study 12891107 — intervention group
Group type: COMPARATOR
Intervention: SMCD and Manual Compression
Number of subjects: 102
Study 10388246 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 166
Study 8671813 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine 10 mg
Number of subjects: 121
Study 8671813 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg
Number of subjects: 121
Study 8671813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 1888640 — intervention group
Group type: EXPERIMENTAL
Intervention: NA 7CH (infinitesimal dilution of nalidixic acid)
Number of subjects: 20
Study 1888640 — intervention group
Group type: COMPARATOR
Intervention: Placebo (succussed water)
Number of subjects: 20
Study 1888640 — intervention group
Group type: EXPERIMENTAL
Intervention: AT 7CH (infinitesimal dilution of atenolol)
Number of subjects: 20
Study 1888640 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 7CH (infinitesimal dilution of bisoprolol)
Number of subjects: 20
Study 1888640 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for atenolol experiment)
Number of subjects: 20
Study 6343154 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous maprotiline (100 mg daily)
Number of subjects: 40
Study 6343154 — intervention group
Group type: COMPARATOR
Intervention: Intravenous clomipramine (Anafranil)
Number of subjects: 40
Study 31955859 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib 24 mg once daily in a 28-day dosing cycle
Number of subjects: 133
Study 31618331 — intervention group
Group type: EXPERIMENTAL
Intervention: BiPAP in post-anesthetic recovery (PAR) for one hour
Number of subjects: 40
Study 31618331 — intervention group
Group type: COMPARATOR
Intervention: BiPAP on the first postoperative day (1PO) for one hour
Number of subjects: 40
Study 31618331 — intervention group
Group type: COMPARATOR
Intervention: Comparison between PAR-G and 1PO-G
Number of subjects: 40
Study 29457388 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme lateral interbody fusion (XLIF)
Number of subjects: 60
Study 29457388 — intervention group
Group type: COMPARATOR
Intervention: Conventional posterior operation
Number of subjects: 60
Study 29457388 — intervention group
Group type: EXPERIMENTAL
Intervention: Both XLIF and Conventional groups
Number of subjects: 60
Study 24942382 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP 200 mg every 2 weeks (Q2W)
Number of subjects: 409
Study 24942382 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP 400 mg every 4 weeks (Q4W)
Number of subjects: 409
Study 24942382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 409
Study 23937679 — intervention group
Group type: EXPERIMENTAL
Intervention: Epelsiban 50 mg
Number of subjects: 77
Study 23937679 — intervention group
Group type: EXPERIMENTAL
Intervention: Epelsiban 150 mg
Number of subjects: 77
Study 23937679 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 20960341 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-D ultrasound for complete tumour removal (group 1)
Number of subjects: 14
Study 20960341 — intervention group
Group type: COMPARATOR
Intervention: 3-D ultrasound for incomplete tumour removal (group 2)
Number of subjects: 14
Study 19782787 — intervention group
Group type: EXPERIMENTAL
Intervention: N-terminal pro-brain natriuretic peptide (NT-proBNP)
Number of subjects: 1383
Study 17572830 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg, 1 hour before bedtime)
Number of subjects: 17
Study 17572830 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light (30‐minute exposure, individually scheduled)
Number of subjects: 17
Study 17572830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 17012882 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP‐IPV//PRP‐T combination vaccine (Pentacel) administered as a fourth dose at 15, 16, 17, or 18 months of age.
Number of subjects: 1782
Study 17012882 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP‐IPV//PRP‐T combination vaccine (Pentacel) administered as a fourth dose.
Number of subjects: 1782
Study 12459073 — intervention group
Group type: EXPERIMENTAL
Intervention: American Heart Association Step II diet for six months
Number of subjects: 191
Study 12459073 — intervention group
Group type: EXPERIMENTAL
Intervention: pravastatin 10 mg
Number of subjects: 191
Study 12459073 — intervention group
Group type: EXPERIMENTAL
Intervention: pravastatin 40 mg
Number of subjects: 191
Study 10588407 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-418 (75 mg/day)
Number of subjects: 32
Study 10588407 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 9180791 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (25,000 IU)
Number of subjects: 35
Study 9180791 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 1872308 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliclazide
Number of subjects: 0
Study 1872308 — intervention group
Group type: COMPARATOR
Intervention: Other sulfonylureas
Number of subjects: 0
Study 1872308 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6353838 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chloroprocaine
Number of subjects: 47
Study 6353838 — intervention group
Group type: COMPARATOR
Intervention: 0.25% bupivacaine
Number of subjects: 47
Study 31125186 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive African Americans
Number of subjects: 2052
Study 29578858 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based aerobic training (WA)
Number of subjects: 40
Study 29578858 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 40
Study 27573315 — intervention group
Group type: EXPERIMENTAL
Intervention: Social POD app (theory‐based podcasts + Social POD app)
Number of subjects: 51
Study 27573315 — intervention group
Group type: COMPARATOR
Intervention: Standard app (theory‐based podcasts + standard app)
Number of subjects: 51
Study 27573315 — intervention group
Group type: EXPERIMENTAL
Intervention: Social POD app
Number of subjects: 51
Study 27573315 — intervention group
Group type: COMPARATOR
Intervention: Standard app
Number of subjects: 51
Study 24549101 — intervention group
Group type: EXPERIMENTAL
Intervention: RG3487 5 mg
Number of subjects: 215
Study 24549101 — intervention group
Group type: EXPERIMENTAL
Intervention: RG3487 50 mg
Number of subjects: 215
Study 24549101 — intervention group
Group type: COMPARATOR
Intervention: RG3487 15 mg
Number of subjects: 215
Study 22242614 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative total parenteral nutrition (TPN) for 18‐90 days (mean, 46 days)
Number of subjects: 120
Study 22242614 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative TPN)
Number of subjects: 120
Study 22242614 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative TPN
Number of subjects: 120
Study 20575726 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation assessment by a remote therapist
Number of subjects: 19
Study 17767002 — intervention group
Group type: EXPERIMENTAL
Intervention: ARC booklet and mind map together
Number of subjects: 363
Study 17767002 — intervention group
Group type: COMPARATOR
Intervention: ARC booklet alone
Number of subjects: 363
Study 16174587 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid injection into the amniotic cavity
Number of subjects: 44
Study 16174587 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion of compound amino acid
Number of subjects: 44
Study 12037731 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g of glucose
Number of subjects: 14
Study 12037731 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g of mannitol
Number of subjects: 14
Study 12037731 — intervention group
Group type: EXPERIMENTAL
Intervention: acute exercise (80 J/kg)
Number of subjects: 14
Study 12037731 — intervention group
Group type: EXPERIMENTAL
Intervention: insulin‐induced hypoglycemia
Number of subjects: 14
Study 10221717 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxin administration (up to 10 times higher than during pregnancy)
Number of subjects: 0
Study 10221717 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxin administration
Number of subjects: 0
Study 8519717 — intervention group
Group type: EXPERIMENTAL
Intervention: Tightly wrapped legs with elastic bandages
Number of subjects: 24
Study 8519717 — intervention group
Group type: COMPARATOR
Intervention: Loosely wrapped legs with elastic bandages (Control)
Number of subjects: 24
Study 2354928 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpretation of chest images with accompanying patient histories
Number of subjects: 247
Study 2354928 — intervention group
Group type: COMPARATOR
Intervention: Interpretation of chest images without accompanying patient histories
Number of subjects: 247
Study 345342 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg glucagon
Number of subjects: 15
Study 345342 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg glucagon
Number of subjects: 15
Study 345342 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg glucagon
Number of subjects: 15
Study 345342 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg glucagon
Number of subjects: 15
Study 345342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 29295829 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication therapy management intervention (single home visit by a pharmacist within 7 days of discharge)
Number of subjects: 141
Study 29295829 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 141